Login to Your Account

Consolidation in Regenerative Medicine Space?

Cytomedix Snags Cell Therapy Firm Aldagen for $16M in Stock

By Marie Powers
Staff Writer

Thursday, February 9, 2012
Cytomedix Inc. drew attention to the regenerative medicine space Wednesday afternoon with the acquisition of privately held Aldagen Inc., which is developing autologous cell-based therapeutics for tissue repair and regeneration.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription